Beth Hecht - See Remarks, Xeris Biopharma Holdings, Inc

As of January 5, 2022


Beth Hecht Net Worth

  • Net worth is estimated to be at least $1.04M
  • Owns at least 57,083 units of Xeris Biopharma Holdings, Inc stock

Beth Hecht Compensation at Xeris Biopharma Holdings, Inc in 2020

  • Earned a $392,852 salary
  • Rewarded $286,650 in stock value and options
  • Received a total compensation of $1,244,394

Beth Hecht Trading

  • Largest purchase of shares was 2,500 units , worth over $25K on February 22, 2019
  • In total has made about 13 transactions over 3 years
  • Usually trades in February, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Beth Hecht Mailing Address

  • Mailing address is C/o Neos Therapeutics, Inc. 2940 N. Highway 360 Grand Prairie TX 75050 TX

Xeris Biopharma Holdings, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Paul Edick, 2020 $626,977 $1,178,450 $ $453,222 $5,700 $2,264,349
Paul Edick, 2019 $598,277 $1,735,000 $1,598,580 $370,181 $5,600 $4,307,638
John Shannon, 2020 $473,658 $414,050 $246,300 $300,000 $2,420 $1,436,428
John Shannon, 2019 $444,479 $ $639,432 $178,500 $5,171 $1,267,582
Beth Hecht, 2020 $392,852 $286,650 $369,450 $189,808 $5,634 $1,244,394
Beth Hecht, 2019 $364,417 $ $259,769 $145,782 $5,600 $775,568
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1346302/000134630221000036/a2021proxystatement.htm

Xeris Biopharma Holdings, Inc Insider Trading

  • The most recent transaction was 100,000 units bought on May 13, 2022 by Paul Edick worth over $140.38K
  • In the last 4 years, insiders at Xeris Biopharma Holdings, Inc sold an estimated value of $3.18M and bought an estimated value of $31.3M
  • The most active traders are Steven Prestrelski, Chief Scientific Officer,  Paul Edick, See Remarks,  and Patrick John Shannon Jr, See Remarks
  • Insider trading is most common in October, with the busiest year in 2021

Xeris Biopharma Holdings, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1